<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Am J Case Rep</journal-id>
      <journal-id journal-id-type="iso-abbrev">Am J Case Rep</journal-id>
      <journal-id journal-id-type="publisher-id">amjcaserep</journal-id>
      <journal-title-group>
        <journal-title>The American Journal of Case Reports</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1941-5923</issn>
      <publisher>
        <publisher-name>International Scientific Literature, Inc.</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25858335</article-id>
      <article-id pub-id-type="pmc">4399480</article-id>
      <article-id pub-id-type="doi">10.12659/AJCR.893218</article-id>
      <article-id pub-id-type="publisher-id">893218</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Bullous Skin Lesions in an Adult Male: A Diagnostic Dilemma</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Gulati</surname>
            <given-names>Gaurav</given-names>
          </name>
          <xref ref-type="author-notes" rid="fn2-amjcaserep-16-215">
            <sup>B</sup>
          </xref>
          <xref ref-type="author-notes" rid="fn5-amjcaserep-16-215">
            <sup>E</sup>
          </xref>
          <xref ref-type="author-notes" rid="fn6-amjcaserep-16-215">
            <sup>F</sup>
          </xref>
          <xref ref-type="aff" rid="af1-amjcaserep-16-215">
            <sup>1</sup>
          </xref>
          <xref ref-type="corresp" rid="c1-amjcaserep-16-215"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Siv</surname>
            <given-names>Jenny</given-names>
          </name>
          <xref ref-type="author-notes" rid="fn2-amjcaserep-16-215">
            <sup>B</sup>
          </xref>
          <xref ref-type="author-notes" rid="fn6-amjcaserep-16-215">
            <sup>F</sup>
          </xref>
          <xref ref-type="aff" rid="af2-amjcaserep-16-215">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ware</surname>
            <given-names>Avis E.</given-names>
          </name>
          <xref ref-type="author-notes" rid="fn5-amjcaserep-16-215">
            <sup>E</sup>
          </xref>
          <xref ref-type="author-notes" rid="fn6-amjcaserep-16-215">
            <sup>F</sup>
          </xref>
          <xref ref-type="aff" rid="af1-amjcaserep-16-215">
            <sup>1</sup>
          </xref>
        </contrib>
      </contrib-group>
      <aff id="af1-amjcaserep-16-215"><label>1</label>Division of Immunology, Allergy and Rheumatology, Department of Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, U.S.A.</aff>
      <aff id="af2-amjcaserep-16-215"><label>2</label>Department of Neurology, University of Washington, Seattle, WA, U.S.A.</aff>
      <author-notes>
        <fn>
          <p>Authors&#x2019; Contribution:</p>
        </fn>
        <fn id="fn1-amjcaserep-16-215">
          <label>A</label>
          <p>Study Design</p>
        </fn>
        <fn id="fn2-amjcaserep-16-215">
          <label>B</label>
          <p>Data Collection</p>
        </fn>
        <fn id="fn3-amjcaserep-16-215">
          <label>C</label>
          <p>Statistical Analysis</p>
        </fn>
        <fn id="fn4-amjcaserep-16-215">
          <label>D</label>
          <p>Data Interpretation</p>
        </fn>
        <fn id="fn5-amjcaserep-16-215">
          <label>E</label>
          <p>Manuscript Preparation</p>
        </fn>
        <fn id="fn6-amjcaserep-16-215">
          <label>F</label>
          <p>Literature Search</p>
        </fn>
        <fn id="fn7-amjcaserep-16-215">
          <label>G</label>
          <p>Funds Collection</p>
        </fn>
        <fn id="fn8-amjcaserep-16-215">
          <p><bold>Conflict of interest:</bold> None declared</p>
        </fn>
        <corresp id="c1-amjcaserep-16-215">Corresponding Author: Gaurav Gulati, e-mail: <email>gaurav.gulati@uc.edu</email></corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>10</day>
        <month>4</month>
        <year>2015</year>
      </pub-date>
      <volume>16</volume>
      <fpage>215</fpage>
      <lpage>219</lpage>
      <history>
        <date date-type="received">
          <day>05</day>
          <month>12</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>01</day>
          <month>1</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Am J Case Rep, 2015</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license>
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License</license-p>
        </license>
      </permissions>
      <abstract>
        <p>
          <bold>Patient: Male, 42</bold>
        </p>
        <p>
          <bold>Final Diagnosis: Henoch-Sch&#xF6;nlein Purpura (HSP)</bold>
        </p>
        <p>
          <bold>Symptoms: Bullous hemorrhagic lesions &#x2022; elevated liver enzymes</bold>
        </p>
        <p>
          <bold>Medication: &#x2014;</bold>
        </p>
        <p>
          <bold>Clinical Procedure: &#x2014;</bold>
        </p>
        <p>
          <bold>Specialty: Rheumatology</bold>
        </p>
        <sec>
          <title>Objective:</title>
          <p>
            <bold>Unusual clinical course</bold>
          </p>
        </sec>
        <sec>
          <title>Background:</title>
          <p>Henoch-Sch&#xF6;nlein Purpura (HSP) is an IgA small-vessel vasculitis that is primarily a disease of childhood. Its presentation in adulthood is rare and has a more severe disease course. We present a case with an atypical presentation of this disease that was a diagnostic challenge for multiple providers.</p>
        </sec>
        <sec>
          <title>Case Report:</title>
          <p>A 42-year-old man noticed bullous lesions over his ankles that spread to his entire legs over a few weeks. They later became necrotic and ulcerated areas. His primary care physician and 2 dermatologists could not reach a definitive diagnosis. He then presented to our hospital with new abdominal pain, rectal bleeding, and a new elevation in liver enzymes. A biopsy of his skin lesions led to the diagnosis of HSP.</p>
        </sec>
        <sec>
          <title>Conclusions:</title>
          <p>We discuss this highly unusual initial presentation with bullous skin lesions and liver enzyme abnormalities and explore the medical literature to understand its pathogenesis. Clinicians need to be aware of this rare presentation to avoid a delay in diagnosis and management.</p>
        </sec>
      </abstract>
      <kwd-group>
        <title>MeSH Keywords</title>
        <kwd>Adult</kwd>
        <kwd>Blister</kwd>
        <kwd>Liver Function Tests</kwd>
        <kwd>Purpura, Schoenlein-Henoch</kwd>
        <kwd>Skin Diseases, Vesiculobullous</kwd>
        <kwd>Transaminases</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>Henoch-Sch&#xF6;nlein purpura (HSP) is the most common vasculitis of childhood but is rare in adults [<xref rid="b1-amjcaserep-16-215" ref-type="bibr">1</xref>]. Adult-onset HSP carries a greater risk of deep organ involvement, especially the renal system, and has a worse outcome [<xref rid="b2-amjcaserep-16-215" ref-type="bibr">2</xref>]. Presence of atypical skin lesions like bullae and necrosis are rare and can be a diagnostic challenge. We discuss a highly unusual presentation of this disease, which caused an initial diagnostic dilemma, and try to understand the pathophysiology of its unique combination of features.</p>
    </sec>
    <sec>
      <title>Case Report</title>
      <p>A previously healthy 42-year-old Caucasian man had an upper respiratory illness that was conservatively managed. About 10 days later, he noticed painless bullous lesions just above his ankles. These continued to erupt, progressing to the proximal lower extremities, and subsequently converted to tense hemorrhagic bullae (<xref ref-type="fig" rid="f1-amjcaserep-16-215">Figure 1</xref>). About 3 weeks following the onset, they opened and started draining sero-sanguinous fluid. By now they had developed into painful crusted and ulcerated areas and limited his movement. Concerned, he saw his primary care provider, who was unsure of the diagnosis and referred him to dermatology. Despite being seen by 2 dermatologists, a definitive diagnosis could not be established.</p>
      <p>Four weeks into his illness, the patient presented to our Emergency Department with sudden-onset epigastric pain, fever of 101&#xB0;F, and rectal bleeding. On examination, he was tachycardic and tachypneic, with upper abdominal tenderness and distention. He had extensive ulcerated and necrotic skin lesions, with some areas of palpable purpura now evident over the upper thighs and abdominal wall and over the flexor surface of his forearms (<xref ref-type="fig" rid="f2-amjcaserep-16-215">Figure 2</xref>).</p>
      <p>Laboratory data revealed a leukocytosis of 22,500 cells/cu mm (N: 4,000&#x2013;11,000), thrombocytosis of 459,000 cells/cu mm (N: 150,000&#x2013;450,000), and mild anemia. His ESR was high at 55 mm/hr, and CRP was elevated at 4.2 mg/dL. The liver profile showed elevated aspartate aminotransferase (AST), ala-nine aminotransferase (ALT), and alkaline phosphatase (ALP) of 75, 105, and 161 U/L, respectively. Viral serology, including a hepatitis panel, was negative. The rest of the laboratory data, including prothrombin time, renal function with electrolytes, and a urinalysis with microscopy were within normal limits. Initial autoimmune work-up including antinuclear antibody (ANA) assay and complete anti-neutrophil cytoplasmic antibody (ANCA) panel with c-ANCA, p-ANCA, myeloperoxidase (MPO), and proteinase 3 (PR 3) was negative. An immunoglobulin panel including IgG subtypes was within normal limits, as were serum complement levels including C3 and C4. There were no other concerns or risk factors noted for immunodeficiency. A chest x-ray and abdominal obstruction series showed no acute findings. A CT scan of the abdomen and pelvis was notable for several dilated loops of small bowel with circumferential mural wall thickening, mesenteric edema, and mild ascites (<xref ref-type="fig" rid="f3-amjcaserep-16-215">Figure 3</xref>). Cultures were obtained and he was admitted for further work-up.</p>
      <p>Even though the cause of his ulcerated bullous lesions and abnormal liver profile was not clear, his now-evident purpura, abdominal complaints and other findings were thought suspicious for an atypical presentation of Henoch-Sch&#xF6;nlein purpura (HSP). A skin biopsy showed intra-epidermal spongiosis with neutrophils, and intra-epidermal small pustules with hemorrhage throughout the papillary dermis. The superficial one-third of the dermis had an intense neutrophilic infiltrate invading most available blood vessels, resulting in fibrinoid degeneration (<xref ref-type="fig" rid="f4-amjcaserep-16-215">Figures 4</xref> and <xref ref-type="fig" rid="f5-amjcaserep-16-215">5</xref>). Immunofluorescence staining revealed intense granular deposition of C3, and moderate deposition of IgA and IgM in the superficial dermal vessel walls. There was diffuse dermal deposition of fibrin but no deposition of IgG. This confirmed the clinical suspicion of HSP and he also met the ACR and EULAR criteria for the diagnosis.</p>
      <p>Given concern of the extent of gastrointestinal involvement and progressive necrotic skin ulcers, he was started on high-dose prednisone at 60 mg a day. He improved and over the next few weeks his leg ulcers healed. His prednisone was tapered and discontinued over the next few months without recurrence. On follow-ups over more than a year, his periodic urinalyses and blood work including liver profile continued to be normal.</p>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>HSP (also known as Sch&#xF6;nlein-Henoch purpura or anaphylactoid purpura) is an IgA-associated small-vessel leukocytoclastic vasculitis [<xref rid="b3-amjcaserep-16-215" ref-type="bibr">3</xref>,<xref rid="b4-amjcaserep-16-215" ref-type="bibr">4</xref>]. Initially described by William Heberden more than 200 years ago, it derives its name from a later description by Johann Lukas Sch&#xF6;nlein (1837) and Eduard Heinrich Henoch (1874) [<xref rid="b5-amjcaserep-16-215" ref-type="bibr">5</xref>]. It is largely a disease of childhood, with a peak incidence at around 4&#x2013;6 years of age [<xref rid="b1-amjcaserep-16-215" ref-type="bibr">1</xref>]. It is, however, rarely reported among adults, in whom the disease is considered to be more severe with relatively poorer prognosis [<xref rid="b2-amjcaserep-16-215" ref-type="bibr">2</xref>].</p>
      <p>Classically, HSP presents with a palpable purpura (in the absence of thrombocytopenia or coagulopathy) and variable involvement of the gastrointestinal, articular, and renal systems. Upper respiratory illness precedes the onset of disease in most cases [<xref rid="b6-amjcaserep-16-215" ref-type="bibr">6</xref>]. A skin biopsy may be required for diagnosis, especially in adults due to its low incidence. The presence of leukocytoclastic vasculitis on light microscopy with IgA immune complex deposition on immunofluorescence is classic and diagnostic of this disease [<xref rid="b3-amjcaserep-16-215" ref-type="bibr">3</xref>,<xref rid="b4-amjcaserep-16-215" ref-type="bibr">4</xref>,<xref rid="b6-amjcaserep-16-215" ref-type="bibr">6</xref>]. Treatment is largely supportive and the role of steroids is controversial [<xref rid="b7-amjcaserep-16-215" ref-type="bibr">7</xref>,<xref rid="b8-amjcaserep-16-215" ref-type="bibr">8</xref>].</p>
      <p>Our patient presented with a set of confusing features &#x2013; bullous and ulcerated lesions &#x2013; as the initial presenting symptom and elevated liver enzymes including alkaline phosphatase. This unique combination of symptoms requires a better understanding of these unusual manifestations in HSP.</p>
      <p>Bullous and necrotic lesions in adult HSP are unusual but the literature is scattered with a highly variable reported incidence. In cases where it is reported, it usually involves co-existing palpable purpura from the onset. Case series by Garc&#xED;a-Porr&#xFA;a et al., Blanco et al, and Byun et al. do not address the presence or absence of these lesions at all, highlighting that these manifestations are possibly under-reported [<xref rid="b2-amjcaserep-16-215" ref-type="bibr">2</xref>,<xref rid="b9-amjcaserep-16-215" ref-type="bibr">9</xref>,<xref rid="b10-amjcaserep-16-215" ref-type="bibr">10</xref>]. Bar-On et al. reported a small number of cases (N=21) but specified that none had bullous features [<xref rid="b11-amjcaserep-16-215" ref-type="bibr">11</xref>]. Cream et al. (1970), in a large series on HSP (N=77), reported a 15.6% incidence of bullous lesions and necrosis of the skin [<xref rid="b5-amjcaserep-16-215" ref-type="bibr">5</xref>]. Poterucha et al. also recently reported a case series of 68 patients, with an incidence of vesicular lesions at around 19% [<xref rid="b12-amjcaserep-16-215" ref-type="bibr">12</xref>].</p>
      <p>It is very interesting to note that Tancrede-Bohin et al. (N=57) report close to 60% incidence of bullous lesions, which is clearly much higher than that reported by others [<xref rid="b13-amjcaserep-16-215" ref-type="bibr">13</xref>]. Even more interesting is that the reported deep-organ involvement (gastrointestinal 19%, renal 23%, and articular 33%) is the lowest among all reported patient series. Their study excluded patients with HSP who had an underlying autoimmune or inflammatory disorder, or associated malignancies, both of which have an association with adult HSP [<xref rid="b14-amjcaserep-16-215" ref-type="bibr">14</xref>]. Both the absence of these co-existing diseases and the lower rate of deep-organ involvement seem to indicate a better prognosis. This conflicts with a recent report by Belli et al., who in their description of 47 Turkish patients found a significant relationship between frequency of bullous and necrotic lesions and the development of gastrointestinal and renal involvement in HSP [<xref rid="b15-amjcaserep-16-215" ref-type="bibr">15</xref>]. They also note an association with IgM and renal involvement, although Poterucha et al. have previously argued against such a relationship in their cohort [<xref rid="b12-amjcaserep-16-215" ref-type="bibr">12</xref>]. This creates a discrepancy about the relationship between bullous lesions and patient prognosis. Importantly, our patient had obvious bullous lesions and some gastrointestinal symptoms with additional presence of IgM on biopsy, but overall positive outcome and no renal involvement.</p>
      <p>There are various hypotheses proposed for the presence of bullous lesions in HSP, mostly from the pediatric literature. These include a pressure hypothesis that describes an increased incidence of bullous lesions in areas of pressure or trauma, especially beneath elastic stockings [<xref rid="b16-amjcaserep-16-215" ref-type="bibr">16</xref>]. There is also a possibility of a pre-existing bullous condition, like dominant dystrophic epidermolysis bullosa (DDEB) as reported by Abdulla et al. [<xref rid="b17-amjcaserep-16-215" ref-type="bibr">17</xref>]. The immunologic explanations, on the other hand, are based on a few reports in which the bullous fluid itself and/or serum were studied. In 1 study the bullous fluid was compared to serum and found to have a 13-fold higher level of soluble CD25 (sCD 25), suggesting dysregulated humoral immunity [<xref rid="b18-amjcaserep-16-215" ref-type="bibr">18</xref>]. There are also reports of increased levels of matrix metalloproteinases (MMPs) in the fluid from bullous lesions demonstrated by immunochemistry staining [<xref rid="b19-amjcaserep-16-215" ref-type="bibr">19</xref>]. This is an interesting finding because a recent meta-analysis of pediatric patients with HSP by Zhou et al. found a strong association of nephritis with serum and even urinary levels of matrix metalloproteinase-9 [OR=77.21, 95% CI: 54.56&#x2013;99.86 and p&lt;0.00001] [<xref rid="b20-amjcaserep-16-215" ref-type="bibr">20</xref>]. Our patient had no past history of bullous lesions but he probably did have association with pressure areas because he wore elastic stockings.</p>
      <p>Our patient had another interesting feature &#x2013; elevated liver enzymes, including alkaline phosphatase. Although this is a unique combination with bullous lesions, there are case reports that mention overlap of HSP with other hepatic diseases. Viola et al. describe a child with HSP and ischemic necrosis of the bile ducts [<xref rid="b21-amjcaserep-16-215" ref-type="bibr">21</xref>]. Although the biopsy did not show positive staining for IgA, the authors thought it was due to a late biopsy, done 44 months after disease onset. Another study describes two cases of primary biliary cirrhosis (PBC), both of which developed biopsy proven HSP [<xref rid="b22-amjcaserep-16-215" ref-type="bibr">22</xref>]. The authors compared PBC pathogenesis with IgA anti-mitochondrial antibodies to HSP with its IgA predominance. It is interesting to note that other vasculitides, such as Kawasaki disease [<xref rid="b23-amjcaserep-16-215" ref-type="bibr">23</xref>], have been shown to have a plasma cell IgA predominance and cytokine mediators similar to those seen in HSP. Interestingly, none of these reports have mentioned presence of bullous lesions in their case descriptions.</p>
      <p>The role of immunosuppression, especially systemic steroids, is controversial in HSP, with arguments both for and against [<xref rid="b7-amjcaserep-16-215" ref-type="bibr">7</xref>,<xref rid="b8-amjcaserep-16-215" ref-type="bibr">8</xref>]. We decided to treat our patient based on abdominal symptoms and extensive necrotic lesions, to aid in early improvement and prevent complications, especially gastrointestinal perforation. The medical literature is clear that renal involvement is not reduced or altered by the use of steroids. The role of corticosteroid use in patients with other manifestations, especially cutaneous bullae or ulcers, remains to be answered.</p>
    </sec>
    <sec sec-type="conclusions">
      <title>Conclusions</title>
      <p>In summary, our patient had a highly unusual onset of HSP with bullous and necrotic skin manifestations and elevated liver enzymes but good overall outcome without relapse or recurrence over a 1-year follow-up. This unique association requires further attention, and may help better understand the pathogenesis and prognostic features of this disease. Providers in adult medicine need to be aware that HSP can present in unusual forms like in our patient, and early recognition with prompt management where indicated can help prevent morbidity and complications.</p>
    </sec>
  </body>
  <back>
    <ack>
      <p>Authors would like to thank Dr. Kerith E. Spicknall, MD Assistant Professor of Dermatology at the University of Cincinnati College of Medicine for providing us images of the patient&#x2019;s histopathology specimen.</p>
    </ack>
    <ref-list>
      <title>References:</title>
      <ref id="b1-amjcaserep-16-215">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gardner-Medwin</surname>
              <given-names>JMM</given-names>
            </name>
            <name>
              <surname>Dolezalova</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Cummins</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Southwood</surname>
              <given-names>TR</given-names>
            </name>
          </person-group>
          <article-title>Incidence of Henoch-Sch&#xF6;nlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins</article-title>
          <source>Lancet</source>
          <year>2002</year>
          <volume>360</volume>
          <issue>9341</issue>
          <fpage>1197</fpage>
          <lpage>202</lpage>
          <pub-id pub-id-type="pmid">12401245</pub-id>
        </element-citation>
      </ref>
      <ref id="b2-amjcaserep-16-215">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Blanco</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Mart&#xED;nez-Taboada</surname>
              <given-names>VM</given-names>
            </name>
            <name>
              <surname>Rodr&#xED;guez-Valverde</surname>
              <given-names>V</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Henoch-Sch&#xF6;nlein purpura in adulthood and childhood: two different expressions of the same syndrome</article-title>
          <source>Arthritis Rheum</source>
          <year>1997</year>
          <volume>40</volume>
          <issue>5</issue>
          <fpage>859</fpage>
          <lpage>64</lpage>
          <pub-id pub-id-type="pmid">9153547</pub-id>
        </element-citation>
      </ref>
      <ref id="b3-amjcaserep-16-215">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mills</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Michel</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Bloch</surname>
              <given-names>DA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The American College of Rheumatology 1990 criteria for the classification of Henoch-Sch&#xF6;nlein purpura</article-title>
          <source>Arthritis Rheum</source>
          <year>1990</year>
          <volume>33</volume>
          <issue>8</issue>
          <fpage>1114</fpage>
          <lpage>21</lpage>
          <pub-id pub-id-type="pmid">2202310</pub-id>
        </element-citation>
      </ref>
      <ref id="b4-amjcaserep-16-215">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ozen</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Pistorio</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Iusan</surname>
              <given-names>SM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>EULAR/PRINTO/PRES criteria for Henoch-Sch&#xF6;nlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria</article-title>
          <source>Ann Rheum Dis</source>
          <year>2010</year>
          <volume>69</volume>
          <issue>5</issue>
          <fpage>798</fpage>
          <lpage>806</lpage>
          <pub-id pub-id-type="pmid">20413568</pub-id>
        </element-citation>
      </ref>
      <ref id="b5-amjcaserep-16-215">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cream</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Gumpel</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Peachey</surname>
              <given-names>RD</given-names>
            </name>
          </person-group>
          <article-title>Sch&#xF6;nlein-Henoch purpura in the adult. A study of 77 adults with anaphylactoid or Sch&#xF6;nlein-Henoch purpura</article-title>
          <source>Q J Med</source>
          <year>1970</year>
          <volume>39</volume>
          <issue>156</issue>
          <fpage>461</fpage>
          <lpage>84</lpage>
          <pub-id pub-id-type="pmid">5532953</pub-id>
        </element-citation>
      </ref>
      <ref id="b6-amjcaserep-16-215">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reamy</surname>
              <given-names>BV</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Lindsay</surname>
              <given-names>TJ</given-names>
            </name>
          </person-group>
          <article-title>Henoch-Sch&#xF6;nlein purpura</article-title>
          <source>Am Fam Physician</source>
          <year>2009</year>
          <volume>80</volume>
          <issue>7</issue>
          <fpage>697</fpage>
          <lpage>704</lpage>
          <pub-id pub-id-type="pmid">19817340</pub-id>
        </element-citation>
      </ref>
      <ref id="b7-amjcaserep-16-215">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Den Boer</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Pasmans</surname>
              <given-names>SGMA</given-names>
            </name>
            <name>
              <surname>Wulffraat</surname>
              <given-names>NM</given-names>
            </name>
          </person-group>
          <article-title>Bullous lesions in Henoch Sch&#xF6;nlein Purpura as indication to start systemic prednisone</article-title>
          <source>Acta Paediatr Oslo Nor 1992</source>
          <year>2010</year>
          <volume>99</volume>
          <issue>5</issue>
          <fpage>781</fpage>
          <lpage>83</lpage>
        </element-citation>
      </ref>
      <ref id="b8-amjcaserep-16-215">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kausar</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yalamanchili</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Management of haemorrhagic bullous lesions in Henoch-Schonlein purpura: is there any consensus?</article-title>
          <source>J Dermatol Treat</source>
          <year>2009</year>
          <volume>20</volume>
          <issue>2</issue>
          <fpage>88</fpage>
          <lpage>90</lpage>
        </element-citation>
      </ref>
      <ref id="b9-amjcaserep-16-215">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Garc&#xED;a-Porr&#xFA;a</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Calvi&#xF1;o</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Llorca</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Henoch-Sch&#xF6;nlein purpura in children and adults: clinical differences in a defined population</article-title>
          <source>Semin Arthritis Rheum</source>
          <year>2002</year>
          <volume>32</volume>
          <issue>3</issue>
          <fpage>149</fpage>
          <lpage>56</lpage>
          <pub-id pub-id-type="pmid">12528079</pub-id>
        </element-citation>
      </ref>
      <ref id="b10-amjcaserep-16-215">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Byun</surname>
              <given-names>J-W</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>H-J</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Predictive factors of relapse in adult with Henoch-Sch&#xF6;nlein purpura</article-title>
          <source>Am J Dermatopathol</source>
          <year>2012</year>
          <volume>34</volume>
          <issue>2</issue>
          <fpage>139</fpage>
          <lpage>44</lpage>
          <pub-id pub-id-type="pmid">22441366</pub-id>
        </element-citation>
      </ref>
      <ref id="b11-amjcaserep-16-215">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bar-On</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Rosenmann</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Schoenlein-Henoch syndrome in adults. A clinical and histological study of renal involvement</article-title>
          <source>Isr J Med Sci</source>
          <year>1972</year>
          <volume>8</volume>
          <issue>10</issue>
          <fpage>1702</fpage>
          <lpage>15</lpage>
          <pub-id pub-id-type="pmid">4636297</pub-id>
        </element-citation>
      </ref>
      <ref id="b12-amjcaserep-16-215">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Poterucha</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Wetter</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Gibson</surname>
              <given-names>LE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Histopathology and correlates of systemic disease in adult Henoch-Sch&#xF6;nlein purpura: a retrospective study of microscopic and clinical findings in 68 patients at Mayo Clinic</article-title>
          <source>J Am Acad Dermatol</source>
          <year>2013</year>
          <volume>68</volume>
          <issue>3</issue>
          <fpage>420</fpage>
          <lpage>424.e3</lpage>
          <pub-id pub-id-type="pmid">22959233</pub-id>
        </element-citation>
      </ref>
      <ref id="b13-amjcaserep-16-215">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tancrede-Bohin</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Ochonisky</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Vignon-Pennamen</surname>
              <given-names>MD</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Sch&#xF6;nlein-Henoch purpura in adult patients. Predictive factors for IgA glomerulonephritis in a retrospective study of 57 cases</article-title>
          <source>Arch Dermatol</source>
          <year>1997</year>
          <volume>133</volume>
          <issue>4</issue>
          <fpage>438</fpage>
          <lpage>42</lpage>
          <pub-id pub-id-type="pmid">9126006</pub-id>
        </element-citation>
      </ref>
      <ref id="b14-amjcaserep-16-215">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Podjasek</surname>
              <given-names>JO</given-names>
            </name>
            <name>
              <surname>Wetter</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Pittelkow</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Wada</surname>
              <given-names>DA</given-names>
            </name>
          </person-group>
          <article-title>Henoch-Sch&#xF6;nlein purpura associated with solid-organ malignancies: three case reports and a literature review</article-title>
          <source>Acta Derm Venereol</source>
          <year>2012</year>
          <volume>92</volume>
          <issue>4</issue>
          <fpage>388</fpage>
          <lpage>92</lpage>
          <pub-id pub-id-type="pmid">22293661</pub-id>
        </element-citation>
      </ref>
      <ref id="b15-amjcaserep-16-215">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Belli</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Dervis</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>The correlation between cutaneous IgM deposition and renal involvement in adult patients with Henoch-Sch&#xF6;nlein purpura</article-title>
          <source>Eur J Dermatol</source>
          <year>2014</year>
          <volume>24</volume>
          <issue>1</issue>
          <fpage>81</fpage>
          <lpage>84</lpage>
          <pub-id pub-id-type="pmid">24509447</pub-id>
        </element-citation>
      </ref>
      <ref id="b16-amjcaserep-16-215">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Matsubara</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Matsubara</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Bullae in pediatric Henoch Sch&#xF6;nlein purpura: why some patients develop them?</article-title>
          <source>Pediatr Dermatol</source>
          <year>2010</year>
          <volume>27</volume>
          <issue>6</issue>
          <fpage>680</fpage>
          <pub-id pub-id-type="pmid">21138472</pub-id>
        </element-citation>
      </ref>
      <ref id="b17-amjcaserep-16-215">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abdulla</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Sheth</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Lucky</surname>
              <given-names>AW</given-names>
            </name>
          </person-group>
          <article-title>Hemorrhagic, bullous Henoch Schonlein purpura in a 16-year-old girl with previously undiagnosed dominant dystrophic epidermolysis bullosa</article-title>
          <source>Pediatr Dermatol</source>
          <year>2010</year>
          <volume>27</volume>
          <issue>2</issue>
          <fpage>203</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="pmid">20537079</pub-id>
        </element-citation>
      </ref>
      <ref id="b18-amjcaserep-16-215">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bansal</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Dwivedi</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Adsett</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Serum and blister fluid cytokines and complement proteins in a patient with Henoch Sch&#xF6;nlein purpura associated with a bullous skin rash</article-title>
          <source>Australas J Dermatol</source>
          <year>1997</year>
          <volume>38</volume>
          <issue>4</issue>
          <fpage>190</fpage>
          <lpage>92</lpage>
          <pub-id pub-id-type="pmid">9431712</pub-id>
        </element-citation>
      </ref>
      <ref id="b19-amjcaserep-16-215">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Park</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Ha</surname>
              <given-names>TS</given-names>
            </name>
            <name>
              <surname>Shin</surname>
              <given-names>JI</given-names>
            </name>
          </person-group>
          <article-title>Matrix metalloproteinases and bullae in pediatric Henoch Sch&#xF6;nlein purpura</article-title>
          <source>Pediatr Dermatol</source>
          <year>2011</year>
          <volume>28</volume>
          <issue>4</issue>
          <fpage>483</fpage>
          <lpage>84</lpage>
          <pub-id pub-id-type="pmid">21793896</pub-id>
        </element-citation>
      </ref>
      <ref id="b20-amjcaserep-16-215">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhou</surname>
              <given-names>T-B</given-names>
            </name>
            <name>
              <surname>Yin</surname>
              <given-names>S-S</given-names>
            </name>
          </person-group>
          <article-title>Association of matrix metalloproteinase-9 level with the risk of renal involvement for Henoch-Sch&#xF6;nlein purpura in children</article-title>
          <source>Ren Fail</source>
          <year>2013</year>
          <volume>35</volume>
          <issue>3</issue>
          <fpage>425</fpage>
          <lpage>29</lpage>
          <pub-id pub-id-type="pmid">23356642</pub-id>
        </element-citation>
      </ref>
      <ref id="b21-amjcaserep-16-215">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Viola</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Meyer</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fabre</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Ischemic necrosis of bile ducts complicating Sch&#xF6;nlein-Henoch purpura</article-title>
          <source>Gastroenterology</source>
          <year>1999</year>
          <volume>117</volume>
          <issue>1</issue>
          <fpage>211</fpage>
          <lpage>14</lpage>
          <pub-id pub-id-type="pmid">10381929</pub-id>
        </element-citation>
      </ref>
      <ref id="b22-amjcaserep-16-215">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gatselis</surname>
              <given-names>NK</given-names>
            </name>
            <name>
              <surname>Stefos</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gioti</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Primary biliary cirrhosis and Henoch-Schonlein purpura: report of two cases and review of the literature</article-title>
          <source>Liver Int Off J Int Assoc Study Liver</source>
          <year>2007</year>
          <volume>27</volume>
          <issue>2</issue>
          <fpage>280</fpage>
          <lpage>83</lpage>
        </element-citation>
      </ref>
      <ref id="b23-amjcaserep-16-215">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rowley</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Shulman</surname>
              <given-names>ST</given-names>
            </name>
          </person-group>
          <article-title>Recent advances in the understanding and management of kawasaki disease</article-title>
          <source>Curr Infect Dis Rep</source>
          <year>2010</year>
          <volume>12</volume>
          <issue>2</issue>
          <fpage>96</fpage>
          <lpage>102</lpage>
          <pub-id pub-id-type="pmid">21308505</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="f1-amjcaserep-16-215" position="float">
      <label>Figure 1.</label>
      <caption>
        <p>Tense bullous lesions over bilateral lower extremities (about week 3 of onset of symptoms).</p>
      </caption>
      <graphic xlink:href="amjcaserep-16-215-g001"/>
    </fig>
    <fig id="f2-amjcaserep-16-215" position="float">
      <label>Figure 2.</label>
      <caption>
        <p>Extensive necrotic skin lesions (on presentation to our hospital Emergency Department). Notice the development of palpable purpura now evident, in addition to the necrotic areas.</p>
      </caption>
      <graphic xlink:href="amjcaserep-16-215-g002"/>
    </fig>
    <fig id="f3-amjcaserep-16-215" position="float">
      <label>Figure 3.</label>
      <caption>
        <p>CT scan of the abdomen showing dilated loops of small bowel with circumferential mural wall thickening (white arrows).</p>
      </caption>
      <graphic xlink:href="amjcaserep-16-215-g003"/>
    </fig>
    <fig id="f4-amjcaserep-16-215" position="float">
      <label>Figure 4.</label>
      <caption>
        <p>Skin biopsy (Medium magnification, H&amp;E Staining) Skin biopsy reveals infiltration of the epidermis by neutrophils, causing neutrophilic vesicles and superficial epidermal degeneration (white arrow). The dermis reveals a dense perivascular and interstitial infiltrate of neutrophils. There is hemorrhage within the epidermis and papillary dermis (black arrow).</p>
      </caption>
      <graphic xlink:href="amjcaserep-16-215-g004"/>
    </fig>
    <fig id="f5-amjcaserep-16-215" position="float">
      <label>Figure 5.</label>
      <caption>
        <p>Skin biopsy (Medium magnification, H &amp; E Staining) Skin biopsy reveals infiltration of the epidermis by neutrophils, causing intra- (black arrow) and subepidermal (white arrow) neutrophilic vesicles and superficial epidermal degeneration. The dermis reveals a dense perivascular and interstitial infiltrate of neutrophils with mild nuclear dust. There is hemorrhage within the epidermis and papillary dermis.</p>
      </caption>
      <graphic xlink:href="amjcaserep-16-215-g005"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
